Trial intelligence / Profile preview

Electrophysiological measurement of ACC function in schizophrenic patients treated with Seroquel or Fluanxol

DRKS00003934Phase 4Completed

Sponsor
University Hospital Würzburg
Start
May 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of quetiapine and flupentixol in schizophrenia, schizophrenia with catatonia and disorganized schizophrenia (2 arms), sponsored by University Hospital Würzburg. Started May 2012; status: completed.

02

Drugs

quetiapineflupentixol
03

Conditions

schizophreniaschizophrenia with catatoniadisorganized schizophrenia

Beyond the preview

Go deeper on DRKS00003934.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00003934.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call